Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TArgeted STEreotactic Radiotherapy for Oligorecurrent PROstate Cancer (TASTEPRO) - a Randomized Controlled Pilot Trial

NCT05067660 is registered in ClinicalTrials.gov with Tampere University Hospital as lead sponsor.

NCT NCT05067660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05067660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TArgeted STEreotactic Radiotherapy for Oligorecurrent PROstate Cancer (TASTEPRO) - a Randomized Controlled Pilot Trial
Lead sponsor
Tampere University Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2022
Completion date
January 1, 2025
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer recurrence after radical prostatectomy